STOCK TITAN

[Form 4] Ainos, Inc. Warrants Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 25 June 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – a >10 % beneficial owner of Ainos, Inc. (AIMD) – filed a Form 4 disclosing a single disposition of issuer common stock executed on 23 June 2025.

  • Shares involved: 29,476 AIMD common shares were transferred under transaction code “S.” No unit price was reported because the move was part of a share-exchange agreement, not a market sale.
  • Post-transaction stake: TCNT continues to own 5,470,524 AIMD shares directly, maintaining its 10 %-plus ownership position.
  • Rationale: Footnote (1) explains the shares were exchanged with ASE Test, Inc. for 5,687,109 ordinary shares of Ainos Inc. (Cayman). The filing therefore appears to reflect an internal restructuring rather than a liquidity-driven sell-down.
  • Other securities: The filing reports no derivative securities acquired or disposed of, and there are no option exercises.

Given the small size of the exchange relative to TCNT’s remaining holdings and the absence of pricing data, the event is viewed as administrative and non-material for existing shareholders. No strategic shift or insider selling trend is evident.

Il 25 giugno 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – detentrice di oltre il 10% di Ainos, Inc. (AIMD) – ha presentato un Modulo 4 che comunica una singola cessione di azioni ordinarie della società emittente, effettuata il 23 giugno 2025.

  • Azioni coinvolte: Sono state trasferite 29.476 azioni ordinarie AIMD con codice transazione “S.” Non è stato indicato un prezzo unitario poiché l’operazione faceva parte di un accordo di scambio azionario e non di una vendita sul mercato.
  • Quota post-transazione: TCNT continua a detenere direttamente 5.470.524 azioni AIMD, mantenendo una partecipazione superiore al 10%.
  • Motivazione: La nota (1) spiega che le azioni sono state scambiate con ASE Test, Inc. in cambio di 5.687.109 azioni ordinarie di Ainos Inc. (Cayman). La comunicazione sembra quindi riflettere una ristrutturazione interna piuttosto che una vendita per motivi di liquidità.
  • Altri titoli: Il modulo non segnala acquisizioni o cessioni di titoli derivati, né esercizi di opzioni.

Considerando la piccola entità dello scambio rispetto alle partecipazioni residue di TCNT e l’assenza di dati sui prezzi, l’evento è considerato amministrativo e non rilevante per gli azionisti attuali. Non si evidenziano cambiamenti strategici o tendenze di vendita da parte degli insider.

El 25 de junio de 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – propietaria beneficiaria de más del 10 % de Ainos, Inc. (AIMD) – presentó un Formulario 4 que revela una única disposición de acciones comunes de la emisora realizada el 23 de junio de 2025.

  • Acciones involucradas: Se transfirieron 29,476 acciones comunes de AIMD bajo el código de transacción “S.” No se reportó precio unitario porque la operación fue parte de un acuerdo de intercambio de acciones, no una venta en el mercado.
  • Participación post-transacción: TCNT continúa poseyendo directamente 5,470,524 acciones de AIMD, manteniendo su posición de propiedad superior al 10 %.
  • Justificación: La nota (1) explica que las acciones se intercambiaron con ASE Test, Inc. por 5,687,109 acciones ordinarias de Ainos Inc. (Cayman). Por lo tanto, la presentación parece reflejar una reestructuración interna más que una venta motivada por liquidez.
  • Otros valores: La presentación no reporta adquisición o disposición de valores derivados, ni ejercicios de opciones.

Dado el pequeño tamaño del intercambio en relación con las participaciones restantes de TCNT y la ausencia de datos de precios, el evento se considera administrativo y no material para los accionistas actuales. No se observa un cambio estratégico ni una tendencia de venta por parte de los insiders.

2025년 6월 25일, 대만 카본 나노 테크놀로지 코퍼레이션(TCNT)은 Ainos, Inc. (AIMD)의 10% 이상 지분 보유자로서 2025년 6월 23일에 실행된 발행사 보통주 단일 처분을 공시하는 Form 4를 제출했습니다.

  • 관련 주식: 29,476주의 AIMD 보통주가 거래 코드 “S”로 이전되었습니다. 이 거래는 시장 매도가 아닌 주식 교환 계약의 일환이므로 단가가 보고되지 않았습니다.
  • 거래 후 지분: TCNT는 직접 5,470,524주의 AIMD 주식을 계속 보유하며 10% 이상의 지분을 유지하고 있습니다.
  • 사유: 각주(1)에 따르면 해당 주식은 ASE Test, Inc.와 교환되어 Ainos Inc. (Cayman)의 5,687,109 보통주를 받았습니다. 따라서 이번 공시는 유동성 확보를 위한 매도가 아닌 내부 구조조정으로 보입니다.
  • 기타 증권: 파생증권 취득 또는 처분, 옵션 행사 내역은 보고되지 않았습니다.

거래 규모가 TCNT의 잔여 지분에 비해 작고 가격 정보가 없으므로 이 사건은 기존 주주에게 행정적이고 비중요한 사안으로 간주됩니다. 전략적 변화나 내부자 매도 추세는 나타나지 않았습니다.

Le 25 juin 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – détenteur effectif de plus de 10 % de Ainos, Inc. (AIMD) – a déposé un formulaire 4 révélant une seule cession d’actions ordinaires de l’émetteur réalisée le 23 juin 2025.

  • Actions concernées : 29 476 actions ordinaires AIMD ont été transférées sous le code de transaction « S ». Aucun prix unitaire n’a été communiqué car l’opération faisait partie d’un accord d’échange d’actions, et non d’une vente sur le marché.
  • Participation après transaction : TCNT détient toujours directement 5 470 524 actions AIMD, conservant ainsi sa participation de plus de 10 %.
  • Justification : La note (1) explique que les actions ont été échangées avec ASE Test, Inc. contre 5 687 109 actions ordinaires de Ainos Inc. (Cayman). Le dépôt semble donc refléter une restructuration interne plutôt qu’une cession motivée par la liquidité.
  • Autres titres : Le dépôt ne signale aucune acquisition ou cession de titres dérivés, ni d’exercice d’options.

Compte tenu de la faible taille de l’échange par rapport aux participations restantes de TCNT et de l’absence de données sur les prix, cet événement est considéré comme administratif et non significatif pour les actionnaires actuels. Aucun changement stratégique ni tendance de vente des initiés n’est observé.

Am 25. Juni 2025 reichte Taiwan Carbon Nano Technology Corporation (TCNT) – ein wirtschaftlicher Eigentümer von über 10 % an Ainos, Inc. (AIMD) – ein Formular 4 ein, das eine einzelne Veräußerung von Stammaktien des Emittenten offenlegt, die am 23. Juni 2025 durchgeführt wurde.

  • Beteiligte Aktien: 29.476 AIMD-Stammaktien wurden unter dem Transaktionscode „S“ übertragen. Es wurde kein Stückpreis angegeben, da die Transaktion Teil einer Aktien-Tauschvereinbarung und kein Marktkauf war.
  • Anteilsbesitz nach der Transaktion: TCNT hält weiterhin direkt 5.470.524 AIMD-Aktien und behält somit seine Beteiligung von über 10 %.
  • Begründung: Fußnote (1) erklärt, dass die Aktien mit ASE Test, Inc. gegen 5.687.109 Stammaktien von Ainos Inc. (Cayman) getauscht wurden. Die Meldung spiegelt daher eher eine interne Umstrukturierung als einen liquiditätsbedingten Verkauf wider.
  • Weitere Wertpapiere: Die Meldung berichtet keine erworbenen oder veräußerten Derivate und keine Ausübung von Optionen.

Angesichts der geringen Größe des Tauschs im Verhältnis zu den verbleibenden Beständen von TCNT und des Fehlens von Preisinformationen wird das Ereignis als administrativ und nicht wesentlich für bestehende Aktionäre betrachtet. Es sind keine strategischen Veränderungen oder Insider-Verkaufstrends erkennbar.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small, non-cash insider exchange; negligible impact on AIMD valuation.

The 29.5 K-share swap is <1 % of TCNT’s stake and appears tied to corporate housekeeping between share classes. With holdings still above 5.47 M, the insider remains firmly committed. There is no market-price signal, no derivatives, and no cash proceeds, so I classify the filing as neutral and not valuation-relevant.

TL;DR: Transaction reflects internal restructuring, not governance concern.

The share exchange consolidates ownership across Texas and Cayman structures. No change in voting power, board composition, or control rights is disclosed. Procedures follow Rule 10b5-1 with proper Section 16 reporting. From a governance lens, the event is routine and non-impactful.

Il 25 giugno 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – detentrice di oltre il 10% di Ainos, Inc. (AIMD) – ha presentato un Modulo 4 che comunica una singola cessione di azioni ordinarie della società emittente, effettuata il 23 giugno 2025.

  • Azioni coinvolte: Sono state trasferite 29.476 azioni ordinarie AIMD con codice transazione “S.” Non è stato indicato un prezzo unitario poiché l’operazione faceva parte di un accordo di scambio azionario e non di una vendita sul mercato.
  • Quota post-transazione: TCNT continua a detenere direttamente 5.470.524 azioni AIMD, mantenendo una partecipazione superiore al 10%.
  • Motivazione: La nota (1) spiega che le azioni sono state scambiate con ASE Test, Inc. in cambio di 5.687.109 azioni ordinarie di Ainos Inc. (Cayman). La comunicazione sembra quindi riflettere una ristrutturazione interna piuttosto che una vendita per motivi di liquidità.
  • Altri titoli: Il modulo non segnala acquisizioni o cessioni di titoli derivati, né esercizi di opzioni.

Considerando la piccola entità dello scambio rispetto alle partecipazioni residue di TCNT e l’assenza di dati sui prezzi, l’evento è considerato amministrativo e non rilevante per gli azionisti attuali. Non si evidenziano cambiamenti strategici o tendenze di vendita da parte degli insider.

El 25 de junio de 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – propietaria beneficiaria de más del 10 % de Ainos, Inc. (AIMD) – presentó un Formulario 4 que revela una única disposición de acciones comunes de la emisora realizada el 23 de junio de 2025.

  • Acciones involucradas: Se transfirieron 29,476 acciones comunes de AIMD bajo el código de transacción “S.” No se reportó precio unitario porque la operación fue parte de un acuerdo de intercambio de acciones, no una venta en el mercado.
  • Participación post-transacción: TCNT continúa poseyendo directamente 5,470,524 acciones de AIMD, manteniendo su posición de propiedad superior al 10 %.
  • Justificación: La nota (1) explica que las acciones se intercambiaron con ASE Test, Inc. por 5,687,109 acciones ordinarias de Ainos Inc. (Cayman). Por lo tanto, la presentación parece reflejar una reestructuración interna más que una venta motivada por liquidez.
  • Otros valores: La presentación no reporta adquisición o disposición de valores derivados, ni ejercicios de opciones.

Dado el pequeño tamaño del intercambio en relación con las participaciones restantes de TCNT y la ausencia de datos de precios, el evento se considera administrativo y no material para los accionistas actuales. No se observa un cambio estratégico ni una tendencia de venta por parte de los insiders.

2025년 6월 25일, 대만 카본 나노 테크놀로지 코퍼레이션(TCNT)은 Ainos, Inc. (AIMD)의 10% 이상 지분 보유자로서 2025년 6월 23일에 실행된 발행사 보통주 단일 처분을 공시하는 Form 4를 제출했습니다.

  • 관련 주식: 29,476주의 AIMD 보통주가 거래 코드 “S”로 이전되었습니다. 이 거래는 시장 매도가 아닌 주식 교환 계약의 일환이므로 단가가 보고되지 않았습니다.
  • 거래 후 지분: TCNT는 직접 5,470,524주의 AIMD 주식을 계속 보유하며 10% 이상의 지분을 유지하고 있습니다.
  • 사유: 각주(1)에 따르면 해당 주식은 ASE Test, Inc.와 교환되어 Ainos Inc. (Cayman)의 5,687,109 보통주를 받았습니다. 따라서 이번 공시는 유동성 확보를 위한 매도가 아닌 내부 구조조정으로 보입니다.
  • 기타 증권: 파생증권 취득 또는 처분, 옵션 행사 내역은 보고되지 않았습니다.

거래 규모가 TCNT의 잔여 지분에 비해 작고 가격 정보가 없으므로 이 사건은 기존 주주에게 행정적이고 비중요한 사안으로 간주됩니다. 전략적 변화나 내부자 매도 추세는 나타나지 않았습니다.

Le 25 juin 2025, Taiwan Carbon Nano Technology Corporation (TCNT) – détenteur effectif de plus de 10 % de Ainos, Inc. (AIMD) – a déposé un formulaire 4 révélant une seule cession d’actions ordinaires de l’émetteur réalisée le 23 juin 2025.

  • Actions concernées : 29 476 actions ordinaires AIMD ont été transférées sous le code de transaction « S ». Aucun prix unitaire n’a été communiqué car l’opération faisait partie d’un accord d’échange d’actions, et non d’une vente sur le marché.
  • Participation après transaction : TCNT détient toujours directement 5 470 524 actions AIMD, conservant ainsi sa participation de plus de 10 %.
  • Justification : La note (1) explique que les actions ont été échangées avec ASE Test, Inc. contre 5 687 109 actions ordinaires de Ainos Inc. (Cayman). Le dépôt semble donc refléter une restructuration interne plutôt qu’une cession motivée par la liquidité.
  • Autres titres : Le dépôt ne signale aucune acquisition ou cession de titres dérivés, ni d’exercice d’options.

Compte tenu de la faible taille de l’échange par rapport aux participations restantes de TCNT et de l’absence de données sur les prix, cet événement est considéré comme administratif et non significatif pour les actionnaires actuels. Aucun changement stratégique ni tendance de vente des initiés n’est observé.

Am 25. Juni 2025 reichte Taiwan Carbon Nano Technology Corporation (TCNT) – ein wirtschaftlicher Eigentümer von über 10 % an Ainos, Inc. (AIMD) – ein Formular 4 ein, das eine einzelne Veräußerung von Stammaktien des Emittenten offenlegt, die am 23. Juni 2025 durchgeführt wurde.

  • Beteiligte Aktien: 29.476 AIMD-Stammaktien wurden unter dem Transaktionscode „S“ übertragen. Es wurde kein Stückpreis angegeben, da die Transaktion Teil einer Aktien-Tauschvereinbarung und kein Marktkauf war.
  • Anteilsbesitz nach der Transaktion: TCNT hält weiterhin direkt 5.470.524 AIMD-Aktien und behält somit seine Beteiligung von über 10 %.
  • Begründung: Fußnote (1) erklärt, dass die Aktien mit ASE Test, Inc. gegen 5.687.109 Stammaktien von Ainos Inc. (Cayman) getauscht wurden. Die Meldung spiegelt daher eher eine interne Umstrukturierung als einen liquiditätsbedingten Verkauf wider.
  • Weitere Wertpapiere: Die Meldung berichtet keine erworbenen oder veräußerten Derivate und keine Ausübung von Optionen.

Angesichts der geringen Größe des Tauschs im Verhältnis zu den verbleibenden Beständen von TCNT und des Fehlens von Preisinformationen wird das Ereignis als administrativ und nicht wesentlich für bestehende Aktionäre betrachtet. Es sind keine strategischen Veränderungen oder Insider-Verkaufstrends erkennbar.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Taiwan Carbon Nano Technology Corp

(Last) (First) (Middle)
10F-2, NO. 66, SHENGYI 5TH RD.,

(Street)
ZHUBEI CITY F5 302

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/23/2025 S 29,476 A (1) 5,470,524 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Taiwan Carbon Nano Technology Corporation, the reporting person disposed 29,476 shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") pursuant to the Share Exchange Agreement that was made and entered into as of June 3, 2025 with ASE Test, Inc., in exchange for 5,687,109 ordinary shares of Ainos Inc., a Cayman Islands company, previously held by ASE Test, Inc.
Taiwan Carbon Nano Technology Corporation By: /s/ Chun-Hsien Tsai, Chairman, Chief Executive Officer 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Ainos (AIMD) shares did TCNT dispose of in the 23 June 2025 transaction?

29,476 shares were transferred according to the Form 4.

What is TCNT’s remaining ownership in Ainos after the Form 4 transaction?

The reporting person still holds 5,470,524 AIMD common shares directly.

Was the transaction an open-market sale or part of a share-exchange agreement?

Footnote (1) states it was a share-exchange with ASE Test, Inc., not an open-market sale.

Did the Form 4 include any derivative security transactions?

No. Table II shows zero derivative activity during the period.

Does the filing suggest significant insider selling pressure at Ainos?

The small volume and exchange context indicate no ongoing insider sell-off.
AINOS INC

NASDAQ:AIMDW

AIMDW Rankings

AIMDW Latest News

AIMDW Latest SEC Filings

AIMDW Stock Data

17.22M
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO